Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing

被引:8
作者
Craig, Wendy Y. [1 ]
Ledue, Thomas B. [1 ]
Collins, Marilyn F. [1 ]
Meggison, William E. [1 ]
Leavitt, Lynda F. [1 ]
Ritchie, Robert F. [1 ]
机构
[1] Fdn Blood Res, Scarborough, ME 04070 USA
关键词
anti-cytoplasmic antibody; anti-nuclear antibody; extractable nuclear antigen; indirect immunofluorescence assay;
D O I
10.1515/CCLM.2006.232
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: There are currently no guidelines concerning additional laboratory testing for specific autoantibodies among anti-nuclear antibody-negative sera with an anti-cytoplasmic staining pattern identified by indirect immunofluorescence assay. Moreover, few data are available that address this laboratory situation. Methods: We performed specific autoantibody assays in 200 sera with an anti-nuclear antibody titer <= 1: 32 and a cytoplasmic titer (undefined staining pattern) of >= 1: 64, identified sequentially in the course of routine anti-nuclear antibody testing. Results: A total of 85 sera (42.5%) were positive in one (n=57) or more (n=28) of the specific autoantibody tests performed. Autoantibodies identified were antimitochondrial (15%), anti-microsomal (13%), anti-neutrophil cytoplasmic (10%), anti-smooth muscle (6%), anti-parietal cell (4%), and extractable nuclear antigen (8.5%, including histones, SSA, SSB, Sm, Jo-1 or Scl-70). A positive result in one or more of these assays was more frequent at anti-cytoplasmic titers >= 1:1024 (77.8%) than at titers of 1:64-1:128 (7%) (chi(2) = 25.3, p < 0.001). Conclusions: The present data demonstrate that undefined anti-cytoplasmic staining in anti-nuclear antibody-negative sera is associated with, although not necessarily caused by, a high frequency and wide range of specific autoantibodies. Further work is needed before specific recommendations can be made concerning follow-up in subjects with this laboratory finding.
引用
收藏
页码:1283 / 1286
页数:4
相关论文
共 19 条
[1]   ANTIMITOCHONDRIAL ANTIBODIES IN PRIMARY BILIARY-CIRRHOSIS AND OTHER DISORDERS - DEFINITION AND CLINICAL RELEVANCE [J].
BERG, PA ;
KLEIN, R .
DIGESTIVE DISEASES, 1992, 10 (02) :85-101
[2]   Antinuclear antibody titer and antibodies to extractable nuclear antigens [J].
Bossuyt, X ;
Hendrickx, A ;
Frans, J .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :987-988
[3]   Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples [J].
Bossuyt, X ;
Luyckx, A .
CLINICAL CHEMISTRY, 2005, 51 (12) :2426-2427
[4]  
Craig WY, 1999, J RHEUMATOL, V26, P914
[5]   ANTIBODIES FROM PATIENTS WITH CONNECTIVE-TISSUE DISEASES BIND SPECIFIC SUBSETS OF CELLULAR RNA-PROTEIN PARTICLES [J].
HARDIN, JA ;
RAHN, DR ;
SHEN, C ;
LERNER, MR ;
WOLIN, SL ;
ROSA, MD ;
STEITZ, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (01) :141-147
[6]  
Hoffman IEA, 2002, CLIN CHEM, V48, P2171
[7]  
Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71
[8]   CYTOPLASMIC ACCUMULATION OF THE 52 KDA RO/SS-A NUCLEAR AUTOANTIGEN IN TRANSFECTED CELL-LINES [J].
KEECH, CL ;
GORDON, TP ;
MCCLUSKEY, J .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (05) :699-712
[9]   CHARACTERIZATION OF ANTICYTOPLASMIC ANTIBODIES AND THEIR CLINICAL ASSOCIATIONS [J].
KOH, WH ;
DUNPHY, J ;
WHYTE, J ;
DIXEY, J ;
MCHUGH, NJ .
ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (04) :269-273
[10]   CYTOPLASMIC STAINING, ANA NEGATIVE STATUS, AND ENA TESTING IN RHEUMATIC DISEASES [J].
LEMS, WF ;
VANSCHAARDENBURG, D ;
VANDESTADT, RJ .
ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (09) :779-779